APOC3 and metabolic dysfunction-associated steatotic liver disease: Increased levels of apo-CIII, in the absence of a high-fat diet, result in increased liver FFA and decreased antioxidant capacity, increased expression of TNF-α and IL-1β, and decreased expression of the adiponectin receptor, all of which have been associated with the development of MASLD [122].